Investing.com2d agobullish
Hims & Hers stock climbs on direct partnership with Eli Lilly for obesity drugsNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3126last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Investor's Business Daily2d agobullish
Hims & Hers Surges On 'Surprising And Inevitable' Deal With Eli Lilly24/7 Wall St.6d agobullish
Eli Lilly Jumped 6% After Earnings. It’s Up 68% in a Year. Where Does the Target Go Now?Motley Fool8d agobullish
After Eli Lilly’s Explosive Earnings Report, Is It Too Late to Buy the Stock?Simply Wall St.44d agobullish
Eli Lilly (LLY) Wins Two FDA Approvals And A $3.35 Billion Drug AllianceMarketWatch64d agobullish
Plastic surgery is booming with boomers. Here’s how to cash in on the antiaging craze.The Wall Street Journal69d agobullish
Eli Lilly to Buy Merida Biosciences for Up to $2.875 BillionThe Wall Street Journal69d agobullish
Eli Lilly to Buy Merida Biosciences for Up to $2.875 BillionMT Newswires75d agobullish
Veeva's Vault CRM Wins Reinforce Market-Leader Status Ahead of Earnings, Truist SaysInvestor's Business Daily86d agobullish
Eli Lilly Stock Nears Buy Point After Earnings-Fueled Gains24/7 Wall St.89d agobullish
Eli Lilly Beat Big and Raised Guidance. Wall Street Sees More Room to RunGuruFocus.com95d agobullish
Eli Lilly and Co (LLY) (Q2 2026) Earnings Call Highlights: Revenue Surges 48% on Zepbound and ...